Previous 10 | Next 10 |
REAL-PE Study Demonstrates Statistically Significant Lower Major Bleeding Rates with the EKOS™ Endovascular System Compared to Mechanical Thrombectomy Device for Treatment of Pulmonary Embolism PR Newswire Analysis is first to compare health system-based electronic heal...
NORTHAMPTON, MA / ACCESSWIRE / October 24, 2023 / Boston Scientific By Paudie O'Connor SVP, Global Supply Chain At Boston Scientific, caring for human life is the common bond that connects our mission, business priorities and environmental, social and governance (ESG) strategy. As we grow t...
2023-10-22 08:13:00 ET Exxon Mobil: Superior Asset Base And Execution To Generate Returns Throughout The Cycle Ford Motor: The Quiet Before The Storm Why I'm Adding To My Coca-Cola Position General Motors makes new 'comprehensive' offer to UAW Apple, Goog...
2023-10-21 12:14:00 ET More on Boston Scientific, DexCom, etc. Intuitive Surgical, Inc. (ISRG) Q3 2023 Earnings Call Transcript Intuitive Surgical: When Paying A Premium Makes Sense Stryker: Don't Buy This Dividend Champion (Yet) Roth MKM starts Stryker with ...
2023-10-19 01:20:00 ET Summary Baron Health Care Fund invests in companies engaged in the research, development, production, sale, delivery, or distribution of products and services related to the health care industry. The Fund trailed the Benchmark by 217 basis points this quarte...
NORTHAMPTON, MA / ACCESSWIRE / October 17, 2023 / Ilonkis Lum first joined the Hispanic Organization for Leadership & Achievement (HOLA) employee resource group (ERG) to meet people outside of her team at Boston Scientific, where she's a Senior Product Owner in the Product Information Manage...
2023-10-13 16:37:00 ET Summary Haemonetics has outperformed the medical device sector, with shares up 7% on very strong revenue growth in plasma collection and good margin leverage. The recent acquisition of OpSens expands Haemonetics' Hospital product portfolio; a specialty guide...
2023-10-12 22:46:40 ET Summary Teleflex shares have lagged a weak medical device market, with growing concerns about the company's internal growth capabilities and its need to turn to pricey M&A. Concerns about the impact of GLP-1 drugs on bariatric surgery may be contributing...
2023-10-12 06:58:38 ET More on the markets Depression Alert: Why The Shrinking Money Supply Spells Trouble For SPY SPY: An Early Contrarian Opportunity (Technical Analysis, Rating Upgrade) Something Will Break Soon Seeking Alpha's quant ratings recommend tech...
2023-10-12 05:03:31 ET Summary Coloplast's shares have lagged behind other medical device companies on worries over margin pressure and aggressive moves to accelerate long-term growth. The company is expected to report organic revenue growth of around 8% for FQ4'23, but concerns r...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Boston Scientific Announces Results for Second Quarter 2024 PR Newswire MARLBOROUGH, Mass. , July 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.120 billion during the second quarter of 2024, growing 14.5 percent ...
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...